FDA Brief

Warning letters Food

FDA warning letter to

Beauty & Spa Concepts, DBA Beenefits

High riskIssued May 24, 2021Posted Jun 8, 2021Center for Food Safety and Applied Nutrition

FDA and FTC warned Beauty & Spa Concepts, DBA Beenefits, over unapproved, misbranded Brazilian Propolis Extract sold with COVID-19 prevention and treatment claims.

What happened

FDA reviewed www.beenefits.com on January 8, 2021, and FTC reviewed it on May 5, 2021; FDA also reviewed the company's Instagram page. The agencies found the site offered Brazilian Propolis Extract for sale and made claims that it could mitigate, prevent, treat, diagnose, or cure COVID-19.

What FDA found

  1. The company sold Brazilian Propolis Extract as a new drug without FDA approval.

    section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. The product was misbranded as a drug.

    section 502 of the FD&C Act, 21 U.S.C. § 352
  3. The letter says introducing the product into interstate commerce is prohibited.

    sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
  4. The company advertised that the product could prevent, treat, or cure disease without competent and reliable scientific evidence.

    FTC Act, 15 U.S.C. 41 et seq.

What FDA wants

FDA asks the company to take immediate action to stop selling any unapproved, unauthorized products for COVID-19 and to email COVID-19-Task-Force-CFSAN@fda.hhs.gov within 48 hours describing corrective steps and how it will prevent recurrence.

Who should pay attention

  • sellers of propolis or other supplements making health claims
  • online retailers and marketplaces hosting COVID-19 claims
  • companies using Instagram testimonials in product marketing

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk